Effect of doublecortin on self-renewal and differentiation in brain tumor stem cells

Cancer Science

Volumn 102, Issue 7, 2011, Pages 1350-1357

  Santra, Manoranjan ^a   Santra, Sutapa ^a   Buller, Ben ^a   Santra, Kastuv ^a   Nallani, Ankita ^a   Chopp, Michael ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DOUBLECORTIN; PHOSPHOPROTEIN PHOSPHATASE 1; PROCASPASE 3; SIMVASTATIN; SPINOPHILIN; STRESS ACTIVATED PROTEIN KINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN TUMOR; CANCER STEM CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL RENEWAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINESIS; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; MICROARRAY ANALYSIS; MICROSCOPY; NERVE CELL; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; TUMOR SUPPRESSOR GENE; UPREGULATION; VIDEORECORDING; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CASPASE 3; CELL DIFFERENTIATION; CELL LINE, TUMOR; GLIOMA; HUMANS; MALE; MICROFILAMENT PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 8; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; NEUROPEPTIDES; PROTEIN PHOSPHATASE 1; RATS; SIMVASTATIN;

EID: 79959245440     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01952.x     Document Type: Article

References (52)

1. Gleeson JG, Allen KM, Fox JW et al. Doublecortin, a brain-specific gene mutated in human X linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 1998; 92: 63-72.
2. Santra M, Santra S, Roberts C et al. Doublecortin induces mitotic microtubule catastrophe and inhibits glioma cell invasion. J Neurochem 2009; 108: 231-45.
3. Santra M, Zhang X, Santra S, Jiang F, Chopp M. Ectopic doublecortin gene expression suppresses the malignant phenotype in glioblastoma cells. Cancer Res 2006; 66: 11726-35.
4. Tatenhorst L, Senner V, Puttmann S et al. Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility. J Neuropathol Exp Neurol 2004; 63: 210-22.
5. Yokota T, Kouno J, Adachi K et al. Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin. Acta Neuropathol 2006; 111: 29-38.
6. Kislin KL, McDonough WS, Eschbacher JM et al. NHERF-1: modulator of glioblastoma cell migration and invasion. Neoplasia 2009; 11: 377-87.
7. Mariani L, McDonough WS, Hoelzinger DB et al. Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection. Cancer Res 2001; 61: 4190-6.
8. Santra M, Zheng X, Roberts C et al. Single doublecortin gene therapy significantly reduces glioma tumor volume. J Neurosci Res 2010; 88: 304-14.
9. Das S, Srikanth M, Kessler JA. Cancer stem cells and glioma. Nat Clin Pract Neurol 2008; 4: 427-35.
10. Ozduman K, Wollmann G, Piepmeier JM, van den Pol AN. Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain. J Neurosci 2008; 28: 1882-9183.
11. Santra M, Eichstetter I, Iozzo RV. An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem 2000; 275: 35153-61.
12. Santra M, Liu XS, Santra S et al. Ectopic expression of doublecortin protects adult mouse progenitor cells and human glioma cells from severe oxygen and glucose deprivation. Neuroscience 2006; 92: 7016-20.
13. Santra M, Mann DM, Mercer EW et al. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J Clin Invest 1997; 100: 149-57.
14. Santra M, Reed CC, Iozzo RV. Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J Biol Chem 2002; 277: 35671-81.
15. Santra M, Skorski T, Calabretta B, Lattime EC, Lozzo RV. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci USA 1995; 92: 7016-20.
16. Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003; 77: 8957-61.
17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-DDC(T)) method. Methods 2001; 254: 402-8.
18. Lee J, Kotliarova S, Kotliarov Y et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9: 391-403.
19. Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
20. Singh SK, Clarke ID, Terasaki M et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-8.
21. Shen Q, Wang Y, Kokovay E et al. Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions. Cell Stem Cell 2008; 3: 289-300.
22. Shen Q, Goderie SK, Jin L et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 2004; 304: 1338-40.
23. Zhang RL, LeTourneau Y, Gregg SR et al. Neuroblast division during migration toward the ischemic striatum: a study of dynamic migratory and proliferative characteristics of neuroblasts from the subventricular zone. J Neurosci 2007; 27: 3157-62.
24. Dykstra B, Ramunas J, Kent D et al. High-resolution video monitoring of hematopoietic stem cells cultured in single-cell arrays identifies new features of self-renewal. Proc Natl Acad Sci USA 2006; 103: 8185-90.
25. Ben-Porath I, Thomson MW, Carey VJ et al. An embryonic stemcell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40: 499-507.
26. Ivanova NB, Dimos JT, Schaniel C et al. Responses to comments on "'Stemness': transcriptional profiling of embryonic and adult stem cells" and "a stem cell molecular signature". Science 2003; 302: 393d.
27. Douglas-Escobar M, Yang C, Bennett J et al. A Pilot Study of Novel biomarkers in neonates with Hypoxic-Ischemic Encephalopathy. Pediatr Res 2010; doi: 10.1203/PDR.0b013e3181f85a03 [Epub ahead of print].
28. Ackerley S, Thornhill P, Grierson AJ et al. Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J Cell Biol 2003; 161: 489-95.
29. Veeranna GJ, Amin ND, Ahn NG et al. Mitogen-activated protein kinases (Erk1, 2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J Neurosci 1998; 18: 4008-21.
30. Wei J, Wu JY. Post-translational regulation of L-glutamic acid decarboxylase in the brain. Neurochem Res 2008; 33: 1459-65.
31. Hou SW, Wang YQ, Xu M et al. Functional integration of newly generated neurons into striatum after cerebral ischemia in the adult rat brain. Stroke 2008; 39: 2837-44.
32. Xie Q, Thompson R, Hardy K et al. A highly invasive human glioblastoma pre-clinical model for testing therapeutics. J Transl Med 2008; 6(77): 1-13.
33. Bello L, Lucini V, Carrabba G et al. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res 2001; 61: 8730-6.
34. Wang R, Chadalavada K, Wilshire J et al. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010; 468: 829-33.
35. Ricci-Vitiani L, Pallini R, Biffoni M et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010; 468: 824-8.
36. Dong J, Zhao Y, Huang Q et al. Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation. Stem Cell Rev 2011; 7: 141-52.
37. Akiyama-Oda Y, Hotta Y, Tsukita S, Oda H. Distinct mechanisms triggering glial differentiation in Drosophila thoracic and abdominal neuroblasts 6-4. Dev Biol 2000; 222: 429-39.
38. Geddis AE, Kaushansky K. Endomitotic megakaryocytes form a midzone in anaphase but have a deficiency in cleavage furrow formation. Cell Cycle 2006; 5: 538-45.
39. Erenpreisa J, Kalejs M, Cragg MS. Mitotic catastrophe and endomitosis in tumour cells: an evolutionary key to a molecular solution. Cell Biol Int 2005; 29: 1012-8.
40. Roy L, Coullin P, Vitrat N et al. Asymmetrical segregation of chromosomes with a normal metaphase/anaphase checkpoint in polyploid megakaryocytes. Blood 2001; 97: 2238-47.
41. Koyuturk M, Ersoz M, Altiok N. Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase. Neurosci Lett 2004; 370: 212-7.
42. Fladmark KE, Brustugun OT, Hovland R et al. Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors. Cell Death Differ 1999; 6: 1099-108.
43. Rich JN, Hans C, Jones B et al. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 2005; 6510: 4051-8.
44. Phillips HS, Kharbanda S, Chen R et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006; 9: 157-73.
45. Rickman DS, Bobek MP, Misek DE et al. Distinctive molecular profiles of highgrade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 2001; 61: 6885-91.
46. Hédou GF, Koshibu K, Farinelli M et al. Protein phosphatase 1-dependent bidirectional synaptic plasticity controls ischemic recovery in the adult brain. J Neurosci 2008; 28: 154-62.
47. Shengui He. Mechanisms of stem cell self-renewal. Annu Rev Cell Dev Biol 2009; 25: 377-406.
48. Reynolds LW, Ingram VM. Erythroid cell differentiation and the inhibition of cytokinesis by cytochalasin. J Cell Biol 1971; 51: 433-9.
49. Ianzini F, Kosmacek EA, Nelson ES et al. Activation of meiosis-specific genes is associated with depolyploidization of human tumor cells following radiation-induced mitotic catastrophe. Cancer Res 2009; 69: 2296-304.
50. Yamashita K, Yasuda H, Pines J et al. Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis-like state in BHK21 cells. EMBO J 1990; 913: 4331-8.
51. Shmueli A, Gdalyahu A, Sapoznik S et al. Site-specific dephosphorylation of doublecortin (DCX) by protein phosphatase 1 (PP1). Mol Cell Neurosci 2006; 32: 15-26.
52. Dong C, Yang DD, Tournier C et al. JNK is required for effector T-cell function but not for T-cell activation. Nature 2000; 405: 91-4.